Frequency of New Hepatocellular Carcinoma in Patients Suffering from Hepatitis C Virus Infection Related Cirrhosis Exposed to Direct Acting Antiviral-based Therapy

Authors

  • Ibtesaam Amjad, Junaid Mushtaq, Kanza Altaf, Ahmed Zaka Subhani, Israr-Ul-Haque Toor, Ghias-Un-Nabi Tayyab

DOI:

https://doi.org/10.53350/pjmhs221631047

Keywords:

Hepatocellular Carcinoma, Hepatitis C virus, Antiviral Therapy

Abstract

Objective: To find the frequency of hepatocellular carcinoma in patients with hepatitis C virus infection patients on dual antiviral therapy.

Design of the study: Cross sectional study

Settings: Department of Medicine/Division of Gastroenterology, Lahore General Hospital, Lahore.

Duration: 6 months

Sample Size: Sample size of 220 cases was calculated with 95% confidence level and 3.5% margin of error by taking percentage of HCC i.e. 7% in HCV patients on direct acting antiviral-based therapy. Data was analyzed with IBM-SPSS version 21. 

Results: In our study the mean age was 37.75±12.08 years. The mean value of duration of HCV therapy of the patients was 8.59±4.023 months. In this study the HCC was noted in 12(5.45%) patients.

Conclusion: The frequency of HCC in patients with HCV infection patients on direct acting antiviral-based therapy is 5.45%.

Downloads

How to Cite

Ibtesaam Amjad, Junaid Mushtaq, Kanza Altaf, Ahmed Zaka Subhani, Israr-Ul-Haque Toor, Ghias-Un-Nabi Tayyab. (2022). Frequency of New Hepatocellular Carcinoma in Patients Suffering from Hepatitis C Virus Infection Related Cirrhosis Exposed to Direct Acting Antiviral-based Therapy. Pakistan Journal of Medical & Health Sciences, 16(03), 1047. https://doi.org/10.53350/pjmhs221631047

Issue

Vol. 16 No. 03 (2022): Pakistan Journal of Medical & Health Sciences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.